Platelet-vessel wall interactions in atherosclerotic disease

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH07-11-0685
Issue:2008: 99/3 (Mar) pp. 457-645
Pages:480-486

Platelet-vessel wall interactions in atherosclerotic disease

Harald F. Langer*, Meinrad Gawaz

Medizinische Klinik III, Klinik für Kardiologie und Kreislauferkrankungen, Eberhard Karls-Universität Tübingen, Tübingen, Germany; *Currently: Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA

Summary

During the prolonged course of atherosclerotic disease,platelets are of central importance as they contribute to the initiation of the disease, to its progression and acute exacerbation but also provide potential regenerative mechanisms. Platelets secrete chemokines and cytokines that mediate vascular inflammation and are in turn activated by substances released from cells of the vascular wall.These interactions represent positive and negative feedback loops, which in case of dysregulation may lead to development and progression of disease. Furthermore, platelet adhesion to the endothelium is critical for the initiation of atherosclerotic lesion formation in vivo. Even prior to endothelial denudation, platelet adhesion governed by disturbed flow at predilection sites for atherosclerosis induces recruitment of proatherosclerotic cells and release of proinflammatory mediators from all involved cell types.Finally,the pathogenetic role of platelets for late atheroclerotic events including plaque rupture, microembolism or spasms within the microcirculation is well established. However, increasing evidence indicates that platelets mediate on the other hand potential regenerative mechanisms. Platelets recruit circulating progenitor cells to sites of vascular injury. Furthermore, they influence their biological activity and maturation. Therefore,platelets contribute at all stages of vascular disease by interfering with highly dynamic processes. Understanding interactions of platelets with other circulating cells and the vascular wall is a prerequisite to understand cardiovascular disease and to identify potential therapeutic targets.

Keywords

stem cells, platelet physiology, atherothrombosis

DOI

http://dx.doi.org/10.1160/TH07-11-0685

You may also be interested in...

1.

C. Giannarelli (1), M. U. Zafar (1), J. J. Badimon (1)

Thrombosis and Haemostasis 2010 104 5: 949-954

http://dx.doi.org/10.1160/TH10-03-0195

2.

María González-Díez, Cristina Rodríguez, Lina Badimon, José Martínez-González

Thrombosis and Haemostasis 2008 100 1: 119-126

http://dx.doi.org/10.1160/TH07-11-0675

3.

Meenu Wadhwa, Robin Thorpe

Thrombosis and Haemostasis 2008 99 5: 863-873

http://dx.doi.org/10.1160/TH07-11-0703



Articles

You've 285 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...